title: Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran.
abstract: We determined the seroprevalence of hepatitis B in Nahavand in a sample of 1824 subjects > 5 years in 2002. Face-to-face interviews were conducted and blood samples taken. The association between risk factor and hepatitis B was assessed using logistic regression. The prevalence of HBsAg positive cases was 2.3%, and HBcAb and HBsAb were isolated in 7.8% and 11.6% of the participants respectively; 11.9% were positive for both HBcAb and HBsAb. History of surgery and imprisonment were the major risk factors for infection with odds ratios of 2.14 (95% CI: 1.22-3.05) and 3.57 (95% CI: 1.68-5.4) respectively.
authors.affiliation: Research Centre of Gastroenterology and Liver Diseases, Shaheed Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran. ahmaliver@yahoo.com
authors.forename: A H M
authors.initials: AH
authors.lastname: Alizadeh
authors.forename: M
authors.initials: M
authors.lastname: Ranjbar
authors.forename: S
authors.initials: S
authors.lastname: Ansari
authors.forename: A
authors.initials: A
authors.lastname: MirArab
authors.forename: S M
authors.initials: SM
authors.lastname: Alavian
authors.forename: K
authors.initials: K
authors.lastname: Mohammad
authors.forename: P
authors.initials: P
authors.lastname: Adibi
authors.forename: Gh H
authors.initials: GH
authors.lastname: Sadri
authors.forename: F
authors.initials: F
authors.lastname: Keramat
authors.forename: A
authors.initials: A
authors.lastname: Ardalan
authors.forename: M
authors.initials: M
authors.lastname: Arabi
authors.forename: S
authors.initials: S
authors.lastname: Gharekhani
authors.forename: A
authors.initials: A
authors.lastname: Ataei
authors.forename: Gh R
authors.initials: GR
authors.lastname: Amraei
authors.forename: M
authors.initials: M
authors.lastname: Hosseinzadeh
authors.forename: S
authors.initials: S
authors.lastname: Hatami
authors.forename: M
authors.initials: M
authors.lastname: Zali
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D003430:Cross-Sectional Studies; D005260:Female; D006509:Hepatitis B / Q000097:blood / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D006512:Hepatitis B Core Antigens / Q000097:blood; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006801:Humans; D007492:Iran / Q000453:epidemiology; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011159:Population Surveillance; D011329:Prisoners / Q000706:statistics & numerical data; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D017678:Sex Distribution; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D011795:Surveys and Questionnaires; D014504:Urban Health / Q000706:statistics & numerical data*; D014611:Vaccination / Q000706:statistics & numerical data
chemical_list: D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens